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SIRT1, a NAD1-dependent protein deacetylase, is an important regulator in cellular stress response and
energy metabolism. While the list of SIRT1 substrates is growing, how the activity of SIRT1 is regulated
remains unclear. We have previously reported that SIRT1 is activated by phosphorylation at a conserved
Thr522 residue in response to environmental stress. Here we demonstrate that phosphorylation of Thr522
activates SIRT1 through modulation of its oligomeric status. We provide evidence that nonphosphorylated
SIRT1 protein is aggregation-prone in vitro and in cultured cells. Conversely, phosphorylated SIRT1 protein
is largely in the monomeric state and more active. Our findings reveal a novel mechanism for environmental
regulation of SIRT1 activity, which may have important implications in understanding the molecular
mechanism of stress response, cell survival, and aging.
T
he sirtuins family of proteins are highly conserved NAD1-dependent protein deacetylases and/or ADP
ribosyltransferases1. The seven mammalian sirtuins, collectively known as SIRT1 to SIRT72, have emerged as
crucial regulators for a variety of cellular processes, ranging from energy metabolism and stress response to
tumorigenesis and possibly aging3. Previous studies have demonstrated that SIRT1, the most conserved mam-
malian sirtuin, directly couples NAD1 hydrolysis to the deacetylation of numerous transcription factors and co-
factors, including p53, E2F1, NFkB, FOXO, PGC-1a, c-myc, HIF-2a, HSF1, CLOCK and PER2, TORC2, as well
as several nuclear receptors3. Therefore, SIRT1 directly links the cellular metabolic status to gene expression,
playing an important role in a number of pro-survival and metabolic activities3,4.
While the list of SIRT1 targets is rapidly expanding, an intricate regulatory network that controls SIRT1
expression and activity has just begun to emerge5,6. This self-contained network functions at different levels and
is critical for maintaining a suitable dosage of SIRT1 in response to various environmental stimuli. For example,
SIRT1 transcription is under the control of multiple negative feedback loops that tightly regulate its activity in
response to cellular stress7. SIRT1 expression is also regulated at the post-transcriptional level by both RNA binding
proteins8 and microRNAs9. Additionally, SIRT1 activity can be directly inhibited10,11 or activated12,13 by several
protein factors, although the biology associated with these protein inhibitors and activators remains to be defined.
Studies from our laboratory and others have recently shown that the activity of SIRT1 can be modulated
by phosphorylation modifications14–17. For instance, we have reported that SIRT1 can be phosphorylated and
activated by two anti-apoptotic members of the DYRK family, DYRK1A and DYRK317. These two kinases directly
interact with SIRT1 and phosphorylate SIRT1 on threonine 522 (Thr522). This modification is sufficient to
activate SIRT1, promoting cell survival in response to various environmental stresses. Interestingly, DYRK1A is
an essential clock component that governs the rhythmic phosphorylation and degradation of CRY2 protein18. The
DYRK1A-SIRT1 link revealed in our previous study suggests that DYRK1A may play a role in the circadian
oscillation of SIRT1 activity19.
In this report, we show that phosphorylation of the Thr522 residue of SIRT1 activates its deacetylase activity
through modulation of its oligomeric state. Non-phosphorylation of Thr522 leads to formation of less-active
oligomers, whereas phosphorylation prevents formation of aggregates and results in SIRT1 activation. Therefore,
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Results
Phosphorylation of Thr522 activates SIRT1 on its native protein
substrate. To elucidate molecular mechanisms underlying the acti-
vation of SIRT1 by phosphorylation, we purified three recombinant
6xHis tagged proteins, wild-type SIRT1 (WT), a non-phosphorylation
mimetic, SIRT1 T522A (TA), and a phosphorylation mimetic, SIRT1
T522E (TE), and analyzed their kinetic behaviors in vitro using acetyl-
p53 as the substrate. Consistent with our previous observations with
GST-tagged recombinant proteins17, all three SIRT1 proteins dis-
played comparable activities when acetyl-p53 levels were low (Figure 1A
and 1B). However, the TE mutant was able to deacetylate p53 at a
higher rate compared to the TA mutant when acetyl-p53 concen-
trations were increased. The recombinant WT SIRT1, which is
nonphosphorylated at Thr52217, behaved similarly as the TA mutant
in this kinetic assay (Figure 1A). Further analyses of recombinant WT
and DYRK1A-phosphorylated WT (p-WT) SIRT1 proteins confirmed
that phosphorylation of Thr522 increased the activity of SIRT1,
particularly at high substrate concentrations (Figure 1C and 1D). As
the nonphosphorylated SIRT1 proteins (WT and TA) were still able
to deacetylate low levels of acetyl-p53 at a comparable rate as the
phosphorylated SIRT1 proteins (TE and p-WT), our data suggest
that the intrinsic catalytic capacity of SIRT1 is not affected by the
phosphorylation status of Thr522, yet the catalytic turnover of this
enzyme is decreased when Thr522 is not phosphorylated.
Non-phosphorylation of Thr522 leads to formation of SIRT1
protein aggregates in vitro. The full-length murine SIRT1 protein
consists of 737 amino acids that can be divided into an enzymatic
Figure 1 | Phosphorylation of Thr522 activates SIRT1 in vitro. (A) Representative in vitro enzymatic analysis of 6xHis tagged WT, TA, and TE SIRT1
proteins. 0.02 mg of purified recombinant WT, TA, or TE SIRT1 proteins were incubated with 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, and 3.0 mg of in vitro acetylated
GST-p53 fusion proteins in the presence of 3 mM of NAD1 and 200 nM of TSA, and incubated at 37uC for 30 min. The acetylated GST-p53 levels were
analyzed as described in the Methods. (B) Quantification of three independent in vitro enzymatic experiments in A. The total and acetylated GST-p53
levels were quantified as described in the Methods. (C) Representative in vitro enzymatic analysis of 6xHis tagged WT SIRT1 (WT) and DYRK1A-
phosphorylated WT SIRT1 (p-WT) proteins. The assays were preformed as described in (A) and the rate of deacetylated p53 levels were analyzed as
described in the Methods. (D) Quantification of three independent in vitro enzymatic experiments as in C. The total and acetylated GST-p53 levels were
quantified as described in the Methods. (*, p,0.05).
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core domain and two flanking non-catalytic N- and C-terminal
domains. The Thr522 residue is localized within a conserved hinge
region linking the core domain and the C-terminal domain17.
Although a recent study has shown that a 25 a.a. sequence located
in the C-terminal domain is essential for SIRT1 activity20, previous
structural studies have suggested that the N- and C-terminal
extensions of sirtuins may function as inhibitory domains to
regulate NAD1 binding and protein substrate recognition21,22. Our
observation that phosphorylation of Thr522 increases the activity of
SIRT1 primarily at high substrate concentrations (Figure 1) suggests
that introduction of a negatively charged phosphate group at this
hinge region likely induces a conformational change that doesn’t
affect the intrinsic catalytic activity of SIRT1, but may help to
reposition the inhibitory N and C-terminal domains, increasing
the accessibility of protein substrates and/or release of protein
products, thereby enhancing catalytic turnover and subsequent
rounds of activity.
To confirm this hypothesis, we analyzed the conformations of the
WT, TA, and TE SIRT1 proteins by various biophysical and bio-
chemical methods. As shown in Figure 2A, dynamic light scattering
analyses revealed that the TA and the TE mutants had distinct size
distribution profiles in solution. The diameter of the TA mutant
peaked around 25 nm, whereas the diameter of the TE mutant
peaked around 18 nm, indicating that the phosphorylation mimetic
is smaller than the non-phosphorylation mimetic. The diameter of
the WT SIRT1, on the other hand, shifted from around 16 nm
to 25 nm when the temperature increased from 4uC to 45uC
(Figure 2A), suggesting that the nonphosphorylated recombinant
WT SIRT1 protein is temperature sensitive. It behaves like the phos-
phorylated protein when temperature is low, but switches to the
conformation of the nonphosphorylated protein when the temper-
ature rises close to physiological or heat shock temperatures. Further
sizing-column coupled multi-angle light scattering experiments per-
formed at room temperature showed that the increased size of the TA
mutant was due to aggregation of the mutant protein (Figure 2B).
The TA mutant formed a heterogeneous mixture of oligomers which
peaked around 300 to 400 kDa (Figure 2B, middle panel), whereas
the TE mutant was eluted as a single smooth peak around 71 kDa
which corresponds to the size of SIRT1 monomers (Figure 2B, bot-
tom panel). Consistent with the dynamic light scattering data, the
WT SIRT1 protein peaked around 211 kDa on the sizing column
at room temperature, suggesting the existence of dimers/trimers
(Figure 2B, top panel). Negative staining electron microscopy con-
firmed that the TA mutant formed heterogeneous aggregates, while
the TE mutant was more uniform and smaller (Figure 2C and
Supplementary Figure 1). Again, the WT SIRT1 protein appeared
to form small oligomers (dimers or trimers) (Figure 2C and
Supplementary Figure 1). Together, our data indicate that phosphor-
ylation of Thr522 is essential to maintain the monomeric state of the
SIRT1 protein. Keeping this site nonphosphorylated leads to oligo-
merization of SIRT1, and while removing the polar side-chain of
Thr522 results in large protein aggregation.
Phosphorylation of Thr522 decreases SIRT1 protein aggregates in
cells and promotes cell survival in response to heat shock. To con-
firm our in vitro biochemical observations that phosphorylation
activates SIRT1 through prevention of protein oligomerization/
aggregation, we transfected stable SIRT1 knockdown HEK293T
cells (HEK293T T1RNAi) with constructs expressing an equal
amount of untagged WT, TA or TE SIRT1 proteins (Sup-
plementary Figure 2). The distribution of these proteins was then
analyzed by Immuno-fluorescent staining and confocal microscopy
imaging. As shown in Figure 3A and 3B, the WT SIRT1 protein,
which can be phosphorylated by DYRKs or possibly other kinases
in cells17, was evenly distributed in the nucleoplasma (top panels).
The TE mutant displayed a similar pattern (bottom panels). The TA
mutant, on the other hand, was highly enriched near the periphery of
nucleus (middle panels), suggesting that this non-phosphorylation
mimetic is either prone to aggregation thus forming large clusters in
cells, or cells are in the process of excluding this mutant from the
center of nucleoplasma. We have previously shown that phospho-
Thr522 levels were significantly elevated after heat shock, a stress
condition known to activate SIRT123, and phosphorylation of Thr522
appears to be essential for SIRT1-mediated heat shock resistance17.
To further confirm our above observations, we heat-shocked
the HEK293T SIRT1 RNAi cells expressing WT, TA, and TE at
45uC for 15 min. The cells were then crosslinked with 0.1% glu-
taraldehyde on ice for indicated time, and the size distribution of
these proteins was analyzed by SDS-PAGE and immunoblotting. As
expected, increasing amounts of SIRT1 proteins migrated at higher
molecular weight with increasing crosslinking time (Figure 3C). The
WT SIRT1 protein and the TE mutant protein had a comparable
amount of high molecular weight mass. The TA mutant protein, on
the other hand, appeared to have more high-molecular weight
aggregates, particularly after 30 min of crosslinking, indicating that
this non-phosphorylation mimetic is prone to aggregation upon heat
shock. Filter-dot blotting analyses of the crosslinked cell lysates
displayed a similar pattern (Figure 3D). Taken together, these
observations demonstrated that phosphorylation of Thr522 pre-
vents the formation of SIRT1 aggregates in cultured cells.
To further investigate the role of Thr522 phosphorylation in cells,
we generated two SIRT1 knockin mouse embryonic fibroblast lines
(MEFs), SIRT1TAKI (TAKI) and SIRT1TEKI (TEKI) (Supple-
mentary Figure 3). We first analyzed the stability of SIRT1 proteins
in these cells upon heat shock treatment. As shown in Figure 4A,
SIRT1 proteins from all three cells, wild-type (WT), TAKI, and
TEKI, were relatively stable within 4 hours after heat shock treat-
ment, indicating that heat shock treatment does not induce the
degradation of SIRT1 proteins in cells. We then examine the forma-
tion of SIRT1 protein aggregates in these cells 30 min after heat
shock treatment (Figure 4B). Although MEFs expressing the TA
mutant protein did not appear to have increased high-molecular-
weight SIRT1 aggregates after heat shock and crosslinking compared
to the WT cells, the TE mutant cells displayed decreased amount of
SIRT1 aggregates. This result supports our hypothesis that phos-
phorylation of Thr522 increases the conformational stability of
SIRT1 protein in cells. We have previously shown that phosphoryla-
tion of Thr522 is required for the pro-survival activity of SIRT1 in
cells in response to heat shock17. Consistent with this notion, the
SIRT1 TE knockin MEFs had higher survival rate 24 hours after
incubation at 45uC for 1 hour (Figure 4C). Collectively, these obser-
vations demonstrate that phosphorylation of Thr522 inhibits the
formation of SIRT1 protein aggregates in cells, thereby activating
SIRT1 and promoting cell survival in response to heat shock stress.
Discussion
As the best-studied member of the sirtuins family, SIRT1 is rising as
an important therapeutic target for a number of age-associated dis-
eases and possibly aging. While much attention has been focused on
the identification of cellular targets of this sirtuin, the network that
regulates SIRT1 expression and activity has just begun to emerge3,5,6.
We have recently shown that SIRT1 can be activated by phosphor-
ylation at a highly conserved Thr522 residue in response to stress17.
In the present study, we show that phosphorylation of this residue
activates SIRT1 by preventing formation of less-active oligomers or
aggregates in vitro (Figure 2) and in cells (Figure 3 and 4), which in
turn promotes cell survival in response to heat shock in cultured cells
(Figure 4). Our findings reveal a novel mechanism that governs the
environmental modulation of SIRT1 activity, suggesting that small
molecules that can modulate the oligomeric states of SIRT1 may
improve cellular stress resistance in response to environmental stress
(Figure 4D).
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Several lines of evidence suggest that although phosphorylation of
Thr522 is essential for the pro-survival activity of SIRT1, the phos-
phorylation status of this residue does not affect the intrinsic catalytic
activity of SIRT1, which is mechanistically different from a recently
discovered phosphorylation modification located in the catalytic
domain of SIRT1 (S434)24. For instance, phosphorylation of
Thr522 does not affect the activity of SIRT1 in vitro when the protein
substrate concentrations are low (Figure 1), nor does it affect the
deacetylase activity on small peptide substrates (not shown), which
most likely reflects the intrinsic catalytic ability of SIRT117,25. Instead,
our data suggest that phosphorylation of Thr522 residue may promote
the activity of SIRT1 through increasing its conformational stability
in response to stress. Firstly, Thr522 phosphorylation does not affect
the dynamic light scattering behavior of the nonphosphorylated
Figure 2 | Non-phosphorylation of Thr522 results in formation of SIRT1 protein aggregates in vitro. (A) The SIRT1 TE mutant proteins displays
smaller size than nonphosphorylated SIRT1 proteins (WT and TA) in solution. Purified recombinant SIRT1 proteins were incubated overnight at 4, 30,
and 45uC respectively, and the solution size of these proteins were determined by dynamic light scattering as described in the Methods. (B) The
nonphosphorylated SIRT1 proteins (WT and TA) are aggregation-prone, whereas the TE mutant proteins are primarily monomers in solution. Purified
recombinant SIRT1 proteins were kept overnight at 4uC and then analyzed at room temperature by sizing-column coupled multi-angle light scattering as
described in the Methods and the molecular weight is calculated across the distribution. (C) Representative negatively stained EM images of samples used
in B. Arrow heads mark SIRT1 oligomers and aggregates in the WT and TA samples.
www.nature.com/scientificreports
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recombinant WT SIRT1 proteins until the temperature rises close to
physiological or stress temperatures (Figure 2A). Secondly, the non-
phosphorylated SIRT1 proteins are prone to oligomerization in res-
ponse to heat shock in cells (Figure 3 and 4). Thirdly, the Thr522 site is
only highly conserved in mammals and birds17, two homeothermic
animals with a body temperature significantly higher than the envir-
onmental temperature. Therefore, phosphorylation of Thr522 may be
a conserved means for homeothermic animals to increase the thermal
stability of SIRT1.
Mutation of threonine or serine to alanine has been routinely used
to mimic the non-phospho-threonine or serine, while glutamate is
well accepted as a phospho-threonine or serine mimetic. Our data
indicate glutamate is an effective phospho-mimetic substitution for
Thr522 of SIRT1 (Figure 1 and Figure 2). However, the alanine
mutant (TA) is noticeably different from the WT recombinant
SIRT1 that is nonphosphorylated at Thr522. For example, the WT
SIRT1 protein only shows a similar solution size as the TA mutant at
high temperature (Figure 2A), and forms small oligomers instead of
large aggregates at room temperature (Figure 2B and 2C). These data
suggest that the polar side-chain of Thr522 also plays a role in the
maintenance of overall integrity of SIRT1 conformation and stability.
Interestingly, when permanently knocked-in in MEF cells, the TA
mutant does not appear to have any effect on SIRT1 oligomerization
or activity (Figure 4B and 4C and Supplementary Figure 3C). One
possible explanation is that phosphorylation of other residues in the
nearby region induced by permanent dephosphorylation of Thr522
may compensate the effect of TA mutation. Further studies are
needed to test this hypothesis. Nevertheless, our previous and present
studies have demonstrated that phosphorylation of Thr522 is essen-
tial to activate SIRT1 in response to various environmental stresses,
and the TE mutant protein has effectively mimicked the effects of the
Thr522 phosphorylation status both in vitro and in cells.
In summary, we have shown that phosphorylation of Thr522 is an
important allosteric mechanism to activate SIRT1 in response to
stress. While non-phosphorylation of this residue leads to formation
of less-active oligomers, phosphorylation helps to maintain the
monomeric status of SIRT1, resulting in increased activity. What
remains to be determined is how phosphorylation status of Thr522
affects the diverse physiological functions of SIRT1 in vivo, and the
precise role of this modification in various pathological conditions.
Methods
Plasmids and antibodies. Untagged mouse SIRT1 was cloned in pcDNA3, or a
modified 6xHis tag vector. The substitution mutants of SIRT1 were constructed by
PCR-based site-directed mutagenesis. Anti-human SIRT1 and anti-mouse SIRT1
antibodies were from Sigma, anti-DYRK1A antibody was from Abnova and anti-
DYRK3 antibody was from Santa Cruz Biotechnology. Anti-acetyl-p53 K382
antibody was from Abcam. Rabbit anti-p-Thr 522 antisera have been described17.
Purification of recombinant SIRT1 proteins. The plasmids encoding 6xHis-tagged
SIRT1 proteins was transformed into BL21DE3 cells and the expression of 6xHis
SIRT1 was induced with isopropyl-b-D-thiogalactopyranoside for overnight at 20uC.
Cells were harvested and sonicated in 50 mM Tris-HCl, pH 8.0, 250 mM NaCl with
1 mM b-mercaptoethanol, 1x protease inhibitor (Roche cocktail). The supernatant
was treated with Benzonase Nuclease (Sigma) for 30 min at room temperature to
digest the nucleic acids. The 6xHis SIRT1 protein was then loaded nickel-
nitrilotriacetic acid resin, washed with 50 mM Tris-HCl, pH 8.0, 250 mM NaCl,
1 mM b-mercaptoethanol, 20 mM imidazole, and eluted with 200 mM imidazole in
50 mM Tris-HCl, pH 8.0, 250 mM NaCl, and 1 mM b-mercaptoethanol. The SIRT1
fractions were pooled and further purified by gel filtration using superdex 200
columns using the same buffer.
In vitro acetylation and deacetylation assays. The in vitro acetylation of GST-p53
was carried out essentially as described26. To analyze the activity of SIRT1 in vitro,
Figure 3 | Phosphorylation of Thr522 activates SIRT1 through preventing the formation of less-active SIRT1 aggregates in cells. (A) Abnormal
accumulation of the SIRT1 TA mutant proteins near the peripheral of nucleus in cells. HEK293T T1RNAi cells were transfected with constructs expressing
indicated SIRT1 proteins. The distribution of these proteins was analyzed by Immuno-fluorescent staining and confocal microscopy imaging as described
in the Methods. (B) The distribution of SIRT1 WT, TA, and TE proteins in 100 nuclei from experiments in A was analyzed along the nuclear diameter as
described in the Methods. (C–D) The SIRT1 TA mutant protein is prone to aggregation upon heat shock in cells. HEK293T T1RNAi cells transfected with
constructs expressing indicated SIRT1 proteins were heat shocked at 45uC for 15 min and cooled down for 15 min on ice. Cells were then crosslinked with
0.1% glutaraldehyde/PBS on ice for indicated time (C) or 30 min (D) and analyzed by SDS-PAGE and immunoblotting (C) or filter dot-blotting (D) as
described in the Methods.
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purified wild-type SIRT1, SIRT1 mutants, and in vitro phosphorylated SIRT1 were
kept at 4uC for overnight, then 0.02 mg of indicated SIRT1 proteins were incubated
with 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, and 3.0 mg of in vitro acetylated GST-p53 fusion
proteins in the deacetylation assay buffer containing 50 mM Tris-HCl, pH 8.0,
137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1 mg/ml BSA, 3 mM of NAD1 and
200 nM of TSA, and incubated at 37uC for 30 min. The total and acetylated GST-p53
levels were quantified with the Odyssey Infrared Imaging System (Li-Cor
Biosciences) using anti-p53 and anti-acetyl-p53 K382 antibodies, and the relative
deacetylated p53 levels were calculated against non-enzyme treated standards (not
shown) and total p53 levels in each samples.
Dynamic light scattering and multi-angle laser light scattering analyses. To analyze
the size of recombinant SIRT1 proteins in solution by dynamic light scattering assays,
the protein samples (0.5 mg/ml) were analyzed using a Zetasizer Nano-S90 light
scattering instrument (Malvern Instruments, Enigma Business Park, UK).
For multi-angle laser light scattering (MALLS) analysis, samples were chromato-
graphed on a Superdex 200 HR (10/30 cm) size exclusion column and eluted with
TBS buffer (0.2 M NaCl, 10mM tris, 10 mM EDTA, pH 7.0) at a flow rate of 0.3
ml/min. The column effluent was passed through an in-line enhanced optimal system
laser photometer (Dawn, Wyatt Technologies) coupled to a digital signal-processing
inferometric refractometer (Optilab, Wyatt) to measure molecular weight and sample
concentration, respectively. The Dawn MAALS measures the light scattered from the
eluant at 18 angles between 10 and 150 degrees. The captured data were integrated
and analyzed with the Astra software provided with the Dawn laser photometer.
Negative staining and electronic microscopy imaging. To analyze the ultrastructure
of recombinant SIRT1 proteins, the samples were negatively stained with 2% uranly
acetate and examined in an FEI Tecnai 12 TEM (Hillsboro, OR). The images were
recorded using a Gatan Inc. Ultrascan400 CCD camera (Pleasanton, CA). Obtained
images were then analyzed by measuring the 2D projection areas of protein particles
using ImageJ and Microsoft Excel, followed by statistical analysis by GraphPad Prism
v5 (GraphPad Software, Inc., La Jolla, CA).
Immuno-fluorescence assay. Cells grown on coverslips were fixed with 4%
paraformaldehyde in PBS at room temperature for 20 min. After washing three times
with PBS, cells were permeabilized with 0.2% Triton X-100 in PBS buffer for 10 min
followed by additional washings. Coverslips were then incubated with primary
antibodies (as indicated) in 10% FBS/PBS for 45 min at room temperature, followed
by 10 min incubation with secondary antibodies. Finally, cells were counterstained
with 49 6-diamidino-2-phenylindole (DAPI) to visualize the nuclei. The slides were
then analyzed on a Zeiss LSM 710 confocal microscope.
To quantify the distribution of SIRT1 proteins in the nucleus, the nuclear diameter
from 100 random selected nuclei per sample were evenly divided into 10 sections. The
intensity of SIRT1 immuno-fluorescent staining in each section was then quantified.
Crosslinking. To analyze the oligomeric status of WT, TA, and TE SIRT1 proteins in
cells, HEK 293T SIRT1 RNAi cells transfected with indicated plasmids or WT, TA,
and TE MEFs were cultured at 37uC or heat shocked at 45uC for 15 min or 30 min.
The cells were then cooled down on ice for 15 min and crosslinked with 0.1%
glutaraldehyde/PBS on ice for 30 min. Crosslinking was stopped by addition 100 mM
glycine. Samples were then collected in SDS-PAGE sample buffer and boiled, and
finally analyzed on 7.5% SDS-PAGE gel or filter-dot-blotting27 followed by immuno-
blotting with indicated antibodies.
Cell viability assay. MEFs were plated into 96-well plate at 50% confluence overnight.
Cells were then treated at 45uC for 1 h, and then recover at 37uC for 24 h. Cell
viability was determined with Cell Proliferation Reagent WST-1 (Roche Applied
Science) according to the manufacturer’s protocol.
Statistical analysis. Values are expressed as mean 6 standard error of mean (SEM).
Significant differences between means was analyzed by two-tailed, unpaired Student’s
t test and differences were considered significant at p, 0.05.
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